Professor Neil Avent has just obtained funding of £166,000 to commercialise blood group genotyping using next generation sequencing, which he has been developing over in our Systems Biology facility. The funding is for two years and has been obtained from Biofortuna Plc, Broxbourne, the Wirral. Below is Dr Kelly Sillence working on the sequencer when she was still a PhD student here. Kelly's work in the School will now be funded by this new grant.